MedPath

Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based Formulas With Different Fat Blends

Phase 4
Completed
Conditions
Infant
Interventions
Other: Infant formula milk based
Registration Number
NCT00941564
Lead Sponsor
Abbott Nutrition
Brief Summary

The objective is to assess the comparative calcium absorption and gastrointestinal (GI) tolerance in healthy normal term infants fed two commercially available powdered milk-based formulas which contain different fat blends.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
33
Inclusion Criteria
  • Infant in good health, full term, singleton birth and 84-156 days of age at enrollment. Male infants only to be enrolled for primary variable measures.
  • Restrict use of certain medications or home remedies, herbal preparations, probiotics or rehydration/intravenous (IV) fluids.
Exclusion Criteria
  • Adverse maternal, fetal or infant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development.
  • Infant has been treated with antibiotics 3 days prior to enrollment.
  • Infant has received probiotics-containing products 3 days prior to enrollment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Commercially available infant formula AInfant formula milk basedVarying fat blend from comparator product
Commercially available infant formula BInfant formula milk based-
Primary Outcome Measures
NameTimeMethod
Calcium absorption18 days
Secondary Outcome Measures
NameTimeMethod
Calcium retention, fat absorption, tolerance18 days

Trial Locations

Locations (1)

Department of Pediatrics, Federal University of Bahia

🇧🇷

Salvador, Bahia, Brazil

© Copyright 2025. All Rights Reserved by MedPath